FDA NDC Directory · JSON-LD · Markdown

Bumetanide

NDC 0641-6008 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerHikma Pharmaceuticals USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA079196
Dosage form / routeINJECTION · INTRAMUSCULAR INTRAVENOUS
Active ingredientsBUMETANIDE (.25 mg/mL)
Marketing started20080430
Package count1

External sources

Source: openFDA. Public-domain (CC0).